|
O.A. Lvova, V.V. Gusev
THE PLACE OF ANTIPLATELET AGENTS IN THE SECONDARY PREVENTION OF ISCHEMIC STROKE IN CHILDREN AND YOUNG PATIENTS
|
№13 / 2014
|
|
A.A. Korolev
EVALUATION OF THE EFFICACY OF MEDICAL REHABILITATION OF POST-STROKE SPASTIC MUSCLE HYPERTONIA AT DIFFERENT STAGES OF DISEASE USING BOTULINUM TOXIN TYPE A
|
№19 / 2013
|
|
Ya.I. Ashikhmin (1), D.Yu.Schekochikhin (2)
INDIVIDUALIZED ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION
|
№18 / 2013
|
|
O.A. Shavlovskaya, MD
FEATURES OF STROKE THERAPY IN DIABETIC PATIENTS
|
№16 / 2013
|
|
S.G. Kanorsky
PREVENTION OF THROMBOEMBOLISM IN PATIENTS WITH ATRIAL FIBRILLATION
|
№10 / 2013
|
|
I.S. Preobrazhenskaya
POSTSTROKE COGNITIVE DISORDERS: CAUSES, CLINICAL PRESENTATIONS, AND TREATMENT
|
№9 / 2013
|
|
M. V. Putilina, M.A.Soldatov
SOME ASPECTS OF DRUG REHABILITATION OF ELDERLY PATIENTS AFTER STROKE
|
№9 / 2013
|
|
M.G. Poluektov, S.L. Tsenteradze
POTENTIALS FOR THE USE OF MELATONIN IN ISCHEMIC STROKE
|
№7 / 2013
|
|
O.V.Kotova
Therapeutic Potentials For The Use Of Melatonin (melaxen) In Stroke
|
№19 / 2012
|
|
O. D. Ostroumova, T.F.Gusev, I.V.Hvorostyany
Blood Pressure Variability – New Target For Stroke Prevention
|
№14 / 2012
|
|
S.A. Zhivolupov, I.N. Samartsev
Modern Clinical Analysis Of Cerebrovascular Diseases: Key Issues Of Differential Diagnosis And Pathogenetic Treatment
|
№7 / 2012
|
|
V.V. Gudkova, T.V. Shanina, K.V. Stakhovskaya
Cytoprotective Properties Of Citicoline: Experimental Prerequisites And Clinical Results
|
№19 / 2011
|
Русский
